Cytisinicline could offer adult cigarette smokers a potential new treatment option

FHS
July 11, 2023
11:23 pm

The first large-scale U.S. clinical trial of cytisinicline, led by a Massachusetts General Hospital (MGH) investigator, found the smoking cessation medication to be effective and well tolerated in adults who wished to break their nicotine dependence.

Physician Fights Insurer to Cover Her Baby’s Brain Cancer Treatment

On June 9, 2023, Eunice Stallman, MD, a psychiatrist in Boise, Idaho, got some of the worst news of her life. The worrisome symptoms she

August 3, 2024

CRO claims there was no misconduct in Lyme vaccine trial it ran for Pfizer

A company that Pfizer blamed for problems with a clinical trial testing a Lyme vaccine claims that regulators gave its procedures a clean bill of

October 11, 2023

Four biotechs emerge with $800M and in-licensed assets on Friday

Four new biotechs launched Friday with megarounds and in-licensed treatment candidates, giving the industry an $800 million boost ahead of the year’s biggest dealmaking event

January 11, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.